Skip to main content

LLORENS Pill - purple oval, 13mm

Generic Name: hyoscyamine/methenamine/methylene blue/phenyl salicylate/sodium biphosphate

Pill with imprint LLORENS is Purple, Oval and has been identified as Urin D/S hyoscyamine 0.12 mg / methenamine 81.6 mg / methylene blue 10.8 mg /phenyl salicylate 36.2 mg / sodium biphosphate 40.8 mg. It is supplied by Llorens Pharmaceutical International Division.

Urin D/S is used in the treatment of Urinary Tract Infection and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Urin D/S hyoscyamine 0.12 mg / methenamine 81.6 mg / methylene blue 10.8 mg /phenyl salicylate 36.2 mg / sodium biphosphate 40.8 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LLORENS

Urin D/S

Generic Name
hyoscyamine/methenamine/methylene blue/phenyl salicylate/sodium biphosphate
Imprint
LLORENS
Strength
hyoscyamine 0.12 mg / methenamine 81.6 mg / methylene blue 10.8 mg /phenyl salicylate 36.2 mg / sodium biphosphate 40.8 mg
Color
Purple
Size
13.00 mm
Shape
Oval
Availability
Prescription only
Drug Class
Urinary antispasmodics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Llorens Pharmaceutical International Division
National Drug Code (NDC)
54859-0701
Inactive Ingredients
carbomer homopolymer type B, magnesium stearate, microcrystalline cellulose, sodium starch glycolate type A corn, calcium phosphate dibasic anhydrous, polydextrose, hypromelloses, D&C Red No. 27, titanium dioxide, FD&C Blue No. 2, triacetin, FD&C Red No. 40, polyethylene glycol, magnesium silicate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related images for "LLORENS"

More about Urin D / S (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate)

Patient resources

Other brands

Uribel, Uro-MP, Uretron DS, Ustell, ... +15 more

Professional resources

Other brands

Uribel, Uretron DS, Phosphasal, Urimar-T, ... +7 more

Related treatment guides

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.